Literature DB >> 31636349

Malignant hypertension: does this still exist?

Magdalena Domek1,2, Jakub Gumprecht1,3, Gregory Y H Lip1,3,4, Alena Shantsila5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31636349     DOI： 10.1038/s41371-019-0267-y

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN： 0950-9240            Impact factor:   3.012


× No keyword cloud information.
  38 in total

1.  Long-term renal survival in malignant hypertension.

Authors:  Roberto González; Enrique Morales; Julian Segura; Luis M Ruilope; Manuel Praga
Journal:  Nephrol Dial Transplant       Date:  2010-03-17       Impact factor: 5.992

Review 2.  Nicardipine, a new intravenous calcium antagonist: a review of its pharmacology, pharmacokinetics, and perioperative applications.

Authors:  P Turlapaty; R Vary; J A Kaplan
Journal:  J Cardiothorac Anesth       Date:  1989-06

3.  Atrial Fibrillation in Patients With Hypertension: Trajectories of Risk Factors in Yet Another Manifestation of Hypertensive Target Organ Damage.

Authors:  Gregory Y H Lip
Journal:  Hypertension       Date:  2016-07-11       Impact factor: 10.190

4.  Ethnic disparities in the incidence, presentation and complications of malignant hypertension.

Authors:  Bert-Jan H van den Born; Richard P Koopmans; Johan O Groeneveld; Gert A van Montfrans
Journal:  J Hypertens       Date:  2006-11       Impact factor: 4.844

5.  Impact of malignant arterial hypertension on the heart.

Authors:  Philippe Gosse; Paul Coulon; Georgios Papaioannou; Jean Litalien; Philippe Lemetayer
Journal:  J Hypertens       Date:  2011-04       Impact factor: 4.844

6.  Bilateral central retinal vein occlusion caused by malignant hypertension in a young patient.

Authors:  Zsuzsa Balogh; András Berta; György Pfliegler; Valéria Nagy
Journal:  Clin Exp Hypertens       Date:  2010-12-19       Impact factor: 1.749

Review 7.  Malignant Hypertension Revisited-Does This Still Exist?

Authors:  Alena Shantsila; Gregory Y H Lip
Journal:  Am J Hypertens       Date:  2017-06-01       Impact factor: 2.689

8.  The clinical presentation of malignant hypertension in Nigerians.

Authors:  S Kadiri; B O Olutade
Journal:  J Hum Hypertens       Date:  1991-08       Impact factor: 3.012

9.  Long-term renal outcome in patients with malignant hypertension: a retrospective cohort study.

Authors:  Fouad Amraoui; Sarah Bos; Liffert Vogt; Bert-Jan van den Born
Journal:  BMC Nephrol       Date:  2012-07-30       Impact factor: 2.388

Review 10.  Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss.

Authors:  Ryan Lee; Tien Y Wong; Charumathi Sabanayagam
Journal:  Eye Vis (Lond)       Date:  2015-09-30
View more
  3 in total

1.  Clinical characteristics and outcomes of a patient population with atypical hemolytic uremic syndrome and malignant hypertension: analysis from the Global aHUS registry.

Authors:  Jean-Michel Halimi; Imad Al-Dakkak; Katerina Anokhina; Gianluigi Ardissino; Christoph Licht; Wai H Lim; Annick Massart; Franz Schaefer; Johan Vande Walle; Eric Rondeau
Journal:  J Nephrol       Date:  2022-09-24       Impact factor: 4.393

Review 2.  Hypertensive eye disease.

Authors:  Carol Y Cheung; Valérie Biousse; Pearse A Keane; Ernesto L Schiffrin; Tien Y Wong
Journal:  Nat Rev Dis Primers       Date:  2022-03-10       Impact factor: 52.329

3.  A Case of Takayasu Arteritis with Thrombotic Microangiopathy Secondary to Malignant Hypertension Due to Bilateral Renal Artery Stenosis.

Authors:  Ege Sinan Torun; Nevzat Koca; Yasemin Yalçınkaya; Bahar Artım Esen; Ahmet Gül; Murat İnanç
Journal:  Open Access Rheumatol       Date:  2022-03-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.